 Against a relatively flat backdrop for the major equity indices, biotechnology firm Iveric Bio NASDAQ: ISEE provided a decisively positive framework, with shares gaining 25 on Friday afternoon. Yesterday, the company disclosed receiving a breakthrough therapy designation for its flagship therapeutic candidate from the Food and Drug Administration FDA. 